An important step in confident canine adrenal care.
Dechra has advanced adrenal function evaluation with CosACTHen®, the first and only FDA-approved cosyntropin for canine patients.
  • Flexible Administration
    Available as a 0.25 mg/ml solution in 1 ml single-use vials for intravenous or intramuscular injection.
  • Well Established Efficacy and Safety
    Evaluated in laboratory and field studies as part of ACTH stimulation testing.
  • Supports Ongoing Patient Management
    May be used to support patient assessment and ongoing care management.
Start Here
to request more information about CosACTHen®

Privacy - Terms